Naoko Takebe to Histone Deacetylase Inhibitors
This is a "connection" page, showing publications Naoko Takebe has written about Histone Deacetylase Inhibitors.
Connection Strength
0.649
-
A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction. Br J Clin Pharmacol. 2019 11; 85(11):2499-2511.
Score: 0.649
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.